OFFICIAL LEGAL TITLE
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_HR_124.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2023-01-09.
What are the main provisions?
Key points include:
- Increased health awareness: Sickle cell patients on Medicaid will receive more information about the risk of renal medullary carcinoma.
- Support for medical education: The act encourages healthcare facilities to provide educational activities in this area.
- Improved healthcare: Better information can lead to earlier detection and treatment of the disease.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Green, Al [D-TX-9].
What is the latest detailed status?
The latest detailed status is: Referred to the Subcommittee on Health.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.